강스템바이오텍
217730KOSDAQ· 의료용 물질 및 의약품 제조업2,125원-15 (-0.70%)전일 종가 2026-09-18
52주 위치
1,3724,69023%신고가 대비 -54.69%
- 시가총액
- 1,999억
- PBR
- 3.53
- BPS
- 601원
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024(별도) | 2025 |
|---|---|---|---|---|---|
| ROE | -31.36% | -34.46% | -45.08% | -17.52% | -18.75% |
| ROA | -21.16% | -21.96% | -28.70% | -11.64% | -15.23% |
| 영업이익률 | -183.28% | -126.12% | -179.29% | -191.62% | -494.56% |
| 순이익률 | -175.96% | -123.78% | -182.78% | -103.15% | -293.00% |
| 매출총이익률 | 21.68% | 29.89% | 12.93% | 55.84% | 23.65% |
| 부채비율 | 56.28% | 70.53% | 82.52% | 29.65% | 18.00% |
| 유동비율 | 290.81% | 232.93% | 195.73% | 368.94% | 525.42% |
| 매출 성장률(YoY) | — | 31.41% | -22.06% | -39.03% | -53.88% |
| FCF | -216억 | -196억 | -179억 | -196억 | -123억 |
| FCF 마진 | -174.32% | -120.10% | -140.82% | -252.79% | -345.33% |
| CAPEX/매출 | 37.33% | 4.37% | 10.96% | 7.66% | 18.50% |
| 항목 | 2021 3Q(별도) | 2021 4Q | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -12.00% | -12.78% | -7.57% | -7.96% | -9.88% | -9.66% | -9.17% | -9.28% | -11.03% | -16.82% | -8.28% | 7.02% | -8.64% | -7.98% | -11.20% | -11.20% | -7.84% | 6.64% | -9.07% | -13.88% |
| ROA | -8.14% | -8.44% | -5.94% | -6.14% | -7.14% | -6.18% | -6.96% | -6.89% | -7.95% | -10.12% | -6.03% | 5.12% | -6.16% | -5.31% | -8.34% | -8.40% | -6.28% | 5.40% | -7.32% | -11.06% |
| 영업이익률 | -1045.09% | -78.44% | -300.88% | -489.18% | -552.59% | -37.26% | -299.96% | -436.15% | -417.17% | -81.56% | -338.62% | -197.74% | -508.50% | -59.12% | -497.17% | -430.42% | -864.63% | -389.45% | -567.65% | -944.26% |
| 순이익률 | -971.12% | -80.69% | -276.37% | -481.89% | -464.74% | -45.43% | -281.00% | -411.35% | -398.98% | -97.12% | -308.82% | 145.58% | -471.91% | -106.99% | -513.76% | -467.46% | -919.09% | 336.57% | -566.56% | -973.42% |
| 매출총이익률 | 31.81% | 19.20% | 58.03% | 42.03% | 27.04% | 25.11% | 47.49% | 30.00% | 37.06% | -0.58% | 41.27% | 40.90% | 46.67% | 73.45% | 21.55% | 9.89% | 45.59% | 28.69% | -4.26% | -13.89% |
| 부채비율 | 47.46% | 56.28% | 27.43% | 29.67% | 32.25% | 70.53% | 37.80% | 42.11% | 48.78% | 82.52% | 36.80% | 33.32% | 34.12% | 29.65% | 31.15% | 33.21% | 17.89% | 18.00% | 19.60% | 20.98% |
| 유동비율 | 599.69% | 290.81% | 1086.53% | 951.24% | 857.10% | 232.93% | 681.22% | 441.56% | 370.24% | 195.73% | 505.91% | 308.84% | 296.84% | 368.94% | 335.87% | 273.43% | 730.18% | 525.42% | 455.61% | 395.93% |
| 매출 성장률(YoY) | — | — | — | — | 110.85% | 15.82% | 2.04% | 15.27% | 26.93% | -32.50% | -29.76% | 96.49% | -39.10% | -59.64% | -25.67% | -54.72% | -38.08% | -67.60% | -15.65% | -37.70% |
| 순이익 성장률(YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -245.41% | — | — | — | — |
| FCF | -54.57억 | -75.09억 | -58.56억 | -40.16억 | -43.32억 | -53.74억 | -49.56억 | -37.99억 | -53.65억 | -37.71억 | -53.78억 | -24.48억 | -43.24억 | -74.3억 | -4.84억 | -33.55억 | -38.44억 | -46.54억 | -35.48억 | -49.44억 |
| FCF 마진 | -1135.33% | -69.62% | -326.87% | -399.71% | -427.43% | -43.02% | -271.13% | -328.04% | -417.04% | -44.72% | -418.88% | -107.59% | -551.95% | -218.35% | -50.73% | -325.61% | -792.37% | -422.09% | -440.71% | -770.06% |
| CAPEX/매출 | 261.95% | 11.76% | 11.20% | 11.81% | 0.69% | 3.09% | 4.93% | 3.28% | 0.35% | 14.94% | 24.16% | 0.00% | 3.57% | 7.50% | 17.13% | 21.92% | 7.14% | 21.48% | 9.43% | 2.67% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 00:33· 연결·별도 혼합 · 산식은 항목 툴팁